Substantia nigra: a site of action of muscle relaxant drugs. 1990

L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
Max-Planck-Institute for Experimental Medicine, Göttingen, Federal Republic of Germany.

Sites of action of centrally active muscle relaxant drugs are not well defined. Clinical experience with such drugs suggests that the spinal cord may be one of the important regions from which pathologically increased muscle tone may be relieved. Supraspinal centers that may also be involved in the expression of muscle relaxant action have not yet been defined. We report here that microinjections of therapeutically relevant muscle relaxants into the midbrain tegmentum of genetically spastic rats decrease muscle tone. The substantia nigra is the region from which midazolam, baclofen, and tizanidine (drugs used clinically in the treatment of spasticity), or gamma-vinyl-GABA, (-)-2-amino-7-phosphonoheptanoate, and [D-pro2-D-phe7-D-trp9]-substance P (experimental drugs active in animal models of spasticity), reduce muscle tone in genetically spastic rats and Hoffmann reflexes in normal rats. The effects of muscle relaxant drugs are topographically restricted to the substantia nigra pars reticulata and are receptor specific. These observations disclose a previously unknown function of the substantia nigra in mediating muscle relaxation.

UI MeSH Term Description Entries
D008297 Male Males
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D009128 Muscle Spasticity A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54) Clasp-Knife Spasticity,Spastic,Clasp Knife Spasticity,Spasticity, Clasp-Knife,Spasticity, Muscle
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005260 Female Females
D006181 H-Reflex A monosynaptic reflex elicited by stimulating a nerve, particularly the tibial nerve, with an electric shock. H Reflex,H-Reflexes,H Reflexes,Reflex, H
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords

Related Publications

L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
June 1990, Brain research,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
June 1988, Neuroscience letters,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
February 1981, Naunyn-Schmiedeberg's archives of pharmacology,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
October 1979, The Practitioner,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
February 1980, British journal of hospital medicine,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
July 1994, Sheng li ke xue jin zhan [Progress in physiology],
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
September 1985, Anesthesia and analgesia,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
September 1971, Masui. The Japanese journal of anesthesiology,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
August 1980, Neuropharmacology,
L Turski, and T Klockgether, and M Schwarz, and W A Turski, and K H Sontag
August 1965, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!